🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could lead to users injecting substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Elimination

According to the social media company, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with photos of slimming results, positive reviews and detailed guides for mixing or administering at residence.

Within minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Item Information and Costs

Within these groups, posts display dark colored packages with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially serious health risks”.